Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Gains from Investment Securities (2016 - 2026)

Innoviva filings provide 17 years of Gains from Investment Securities readings, the most recent being $17000.0 for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities fell 99.18% to $17000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $17000.0, a 99.18% decrease, with the full-year FY2025 number at $17000.0, down 99.18% from a year prior.
  • Gains from Investment Securities hit $17000.0 in Q4 2025 for Innoviva, down from $13.1 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $178.4 million in Q3 2021 to a low of -$112.6 million in Q2 2021.
  • Median Gains from Investment Securities over the past 5 years was $1.2 million (2022), compared with a mean of $12.7 million.
  • The widest YoY moves for Gains from Investment Securities: up 10526.83% in 2025, down 152.81% in 2025.
  • Innoviva's Gains from Investment Securities stood at $766000.0 in 2021, then increased by 23.76% to $948000.0 in 2022, then soared by 58.12% to $1.5 million in 2023, then surged by 37.89% to $2.1 million in 2024, then tumbled by 99.18% to $17000.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $17000.0 (Q4 2025), $13.1 million (Q3 2025), and $12.7 million (Q2 2025) per Business Quant data.